(Q38577875)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26325242%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Ebola virus vaccine: benefit and risks of adenovirus-based vectors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26325242%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

main subject

Ebola vaccine

0 references

Orthoebolavirus zairense

0 references

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26325242%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Philippe Van de Perre

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26325242%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Eric J Kremer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26325242%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Franck J D Mennechet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26325242%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Thi Thu Phuong Tran

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26325242%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

31 August 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26325242%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26325242%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26325242%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26325242%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

1471-1478

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26325242%20AND%20SRC:MED&resulttype=core&format=json

Outbreak of ebola virus disease in Guinea: where ecology meets economy

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

The evolution of adenoviral vectors through genetic and chemical surface modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Development of a preventive vaccine for Ebola virus infection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Frequency, proliferation, and activation of human memory T cells induced by a nonhuman adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Immunology. Immune activation with HIV vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Ebola vaccines based on adenovirus vectors and risk of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 va

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Merck Ad5/HIV induces broad innate immune activation that predicts CD8⁺ T-cell responses but is attenuated by preexisting Ad5 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

21 January 2018

Ebola's perfect storm

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Corrective GUSB transfer to the canine mucopolysaccharidosis VII brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Do nonhuman primate or bat adenoviruses pose a risk for human health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Central nervous system delivery of helper-dependent canine adenovirus corrects neuropathology and behavior in mucopolysaccharidosis type VII mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Corrective GUSB transfer to the canine mucopolysaccharidosis VII cornea using a helper-dependent canine adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Human coagulation factor X-adenovirus type 5 complexes poorly stimulate an innate immune response in human mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Adenovirus tales: from the cell surface to the nuclear pore complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429

Circuit Architecture of VTA Dopamine Neurons Revealed by Systematic Input-Output Mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1083429